Polpharma is a major manufacturer of pharmaceuti
The Starogard Gdanski facility is one of the largest and most modern drug manufacturing plants in Europe. Here Polpharma manufactures a wide variety of products and forms:
Solid forms include tablets, film-coated tablets, effervescent tablets, sugar coated tablets, and capsules. The annual manufacturing capacity of solid forms is 6 billion units.
Parenteral drugs include injectable preparations in polyethylene packaging and glass ampoules, single- and multi-dose eye drops控制工程网版权所有, nasal drops控制工程网版权所有, infusion fluids, and fluids for external use. In 2005CONTROL ENGINEERING China版权所有, the company started up a new ampoule filling facility, constructed in compliance with strict GMP (good manufacturing practice) standards for sterile manufacturing.
Active pharmaceutical ingredients (API), with reactor capacity of 320CONTROL ENGINEERING China版权所有,000 liters. API manufacturing facilities are regularly audited by the FDA.
All manufacturing units in the plant have GMP certificates issued by the Main Pharmaceutical Inspectorate and PIC/S (Pharmaceutical Inspection Cooperation Scheme). Polpharma also offers contract manufacturing services of both drug products and active pharmaceutical ingredients.
Polpharma has used Honeywell


在线会议
论坛
专题
工控直播
新闻中心
子站
技术
社区


2026具身智能机器人电子制造应用研讨会
福禄克六大“法宝”帮您搞定过程仪表校准难题
中控时间序列大模型TPT免费有奖体验
爱德克SE2L进阶版安全激光扫描仪有奖预约演示
剑维软件电子半导体行业白皮书有奖下载





















